Disc Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	88.91	91.15	192.43	360.38	194.61	88.04
Short-Term Investments	641.25	700.01	297.45	-	-	-
Cash & Short-Term Investments	730.16	791.15	489.88	360.38	194.61	88.04
Cash Growth	5.11%	61.50%	35.93%	85.18%	121.06%	1855.05%
Other Current Assets	17.3	12.75	3.73	5.28	3.88	2.45
Total Current Assets	747.46	803.9	493.62	365.66	198.49	90.48
Net Property, Plant & Equipment	2.04	1.91	2.67	2.1	1.6	1.75
Other Long-Term Assets	0.72	0.73	0.84	0.23	0.12	0.18
Total Assets	750.21	806.88	496.77	368	200.21	92.41
Accounts Payable	11.76	9.02	7.95	12.63	16.16	2.56
Accrued Expenses	18.96	27.01	15.24	8.15	6.11	4.1
Current Portion of Leases	0.42	0.61	0.13	0.67	0.31	0.32
Total Current Liabilities	31.14	36.64	23.32	21.44	22.58	6.97
Long-Term Debt	29.37	29.16	28.32	-	-	-
Long-Term Leases	1.28	1.25	1.55	1.44	1.03	1.33
Other Long-Term Liabilities	-	-	-	-	-	6.45
Total Long-Term Liabilities	30.64	30.41	29.87	1.44	1.03	7.78
Total Liabilities	61.78	67.05	53.19	22.88	23.61	14.76
Common Stock	0	0	0	0	0	-
Additional Paid-in Capital	1,263	1,249	741.3	533.76	288.81	1.19
Accumulated Other Comprehensive Income	-0.57	0.97	0.29	-	-	-
Retained Earnings	-573.69	-510.19	-298	-188.65	-112.22	-65.39
Total Common Shareholders' Equity	688.43	739.83	443.59	345.12	176.6	-64.2
Minority Interest	-	-	-	-	-	141.86
Shareholders' Equity	688.43	739.83	443.59	345.12	176.6	77.65
Total Liabilities & Equity	750.21	806.88	496.77	368	200.21	92.41
Total Debt	31.06	31.02	30	2.1	1.33	1.65
Net Cash (Debt)	699.1	760.13	459.88	358.28	193.28	86.38
Net Cash Growth	-8.03%	65.29%	28.36%	85.37%	123.74%	-
Net Cash Per Share	19.11	21.54	16.66	16.05	185.93	98.34
Book Value	688.43	739.83	443.59	345.12	176.6	-64.2
Book Value Per Share	18.82	20.96	16.07	15.47	169.89	-73.09
Tangible Book Value	688.43	739.83	443.59	345.12	176.6	-64.2
Tangible Book Value Per Share	18.82	20.96	16.07	15.47	169.89	-73.09

SEC Filings: 10-K · 10-Q